Literature DB >> 18257060

The rate of urinary cortisol excretion at work is persistently elevated in women at familial risk for breast cancer.

Gary D James1, Heidi J Gastrich, Heiddis B Valdimarsdottir, Dana H Bovbjerg.   

Abstract

We recently reported that healthy women at familial risk for breast cancer (FH+) have higher urinary cortisol levels at work than women without familial risk (FH-). The purpose of this study was to evaluate whether this group difference persisted over a 1-month period. Subjects were healthy women (FH+, N = 42, age = 37.6 +/- 9.3, FH-, N = 93, age 38.4 +/- 9.0) employed primarily in clerical or technical positions at three medical centers in New York City who collected timed urine samples in three contrasting daily environments, at work ( approximately 11AM-3PM), home (approximately 6PM-10PM) and during sleep (approximately 10PM-6AM) on 2 mid-week workdays approximately 1 month apart. Two-way repeated measures ANOVA revealed that cortisol excretion differed across the environments (P < 0.001), and that there was also a significant interaction between daily environment and family history group (P < 0.049), such that FH+ women maintained higher cortisol excretion at work over the 2 days than FH- women. A Bland-Altman plot showed that both overall and by family history group, the rate of cortisol excretion at work was generally reproducible, although there was a heteroscadasticity in the relationship that likely reflected excessive stressfulness on one of the study days in a small minority of subjects. These results suggest that the presence of a potent background stressor (familial breast cancer risk) can influence more acute cortisol responses in daily life over time. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257060     DOI: 10.1002/ajhb.20737

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  6 in total

1.  Cognitive Behavioral Stress Management for Healthy Women at Risk for Breast Cancer: a Novel Application of a Proven Intervention.

Authors:  Bonnie A McGregor; Emily D Dolan; Karly M Murphy; Timothy S Sannes; Krista B Highland; Denise L Albano; Alison A Ward; Anna M Charbonneau; Mary W Redman; Rachel M Ceballos
Journal:  Ann Behav Med       Date:  2015-12

2.  Differential circadian catecholamine and cortisol responses between healthy women with and without a parental history of hypertension.

Authors:  Gary D James; Alexandria S Alfarano; Helene M van Berge-Landry
Journal:  Am J Hum Biol       Date:  2014-07-15       Impact factor: 1.937

Review 3.  Searching for the noninvasive biomarker holy grail: are urine proteomics the answer?

Authors:  Joachim Voss; Young Ah Goo; Kevin Cain; Nancy Woods; Monica Jarrett; Lynne Smith; Robert Shulman; Margaret Heitkemper
Journal:  Biol Res Nurs       Date:  2011-05-17       Impact factor: 2.522

4.  Comparison of pre- and post-operative stress levels in patients with allergic rhinitis and non-allergic rhinitis.

Authors:  Dae Han Chung; Kun Hee Lee; Sung Wan Kim; Seung Youp Shin; Joong Saeng Cho
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-14       Impact factor: 2.503

5.  Urinary Iodine Concentrations in Cancer Patients

Authors:  Saeed Kargar; Seyed Mostafa Shiryazdi; Seyed Reza Atashi; Hossein Neamatzadeh; Mahdieh Kamali
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

6.  The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids.

Authors:  Lauren C Houghton; Renata E Howland; Ying Wei; Xinran Ma; Rebecca D Kehm; Wendy K Chung; Jeanine M Genkinger; Regina M Santella; Michaela F Hartmann; Stefan A Wudy; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-30       Impact factor: 4.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.